Aim People with rheumatic diseases (PRD) remain vulnerable in the era of the COVID‐19
pandemic. We formulated recommendations to meet the urgent need for a consensus for …

Background Although lifestyle interventions are commonly recommended in the management
of patients with chronic gout, the evidence from trial data for their benefits and safety has …

… Our original review only included one study looking at a single drug intervention (Sriranganathan
2014). It is important to update this review for recent evidence on the available interventions …

Objective. To determine the efficacy and safety of lifestyle interventions for treating gout.
Methods. Two Cochrane systematic reviews assessed the efficacy and safety of lifestyle …

Objective. To systematically review the available literature on the management of tophi in gout.
This article is based on the Cochrane Review Interventions for Tophi in Gout published in …

Background Although lifestyle interventions are often recommended in the management of
chronic gout, the evidence from trial data of the benefits and safety of using lifestyle …

Gout is the most common type of inflammatory arthritis, and its impact on cardiovascular
health and quality of life is often underestimated. The prevalence and incidence of gout are …

AimPeople with rheumatic diseases (PRD) remain vulnerable in the era of the COVID-19
pandemic. We formulated recommendations to meet the urgent need for a consensus for …

… Melonie K. Sriranganathan, et al. … Kaarela K, Ekman P, Luukkainen R. Rasburicase in
tophaceous gout: A case report. …

Systemic lupus erythematosus is a heterogeneous autoimmune disease caused by genetic
and environmental factors. It is recognized that patients from different racial backgrounds …